Skip to main content
. 2019 Mar 27;63(4):e02158-18. doi: 10.1128/AAC.02158-18

TABLE 2.

MICs obtained for lefamulin and comparator agents tested against isolates included in the studya

Collection no. Species MIC (µg/ml) by agent
Erythromycin Clindamycin Q-D Linezolid Lefamulin Retapamulin Chloramphenicol
975498 S. aureus >8 >64 0.5 1 0.5 (0.5) ≤0.06 16
981256 S. aureus 0.12 ≤0.5 0.5 1 0.5 (0.5) 0.5 4
924825 S. aureus >8 ≤0.5 0.5 1 1 (1) 2 8
953474 S. aureus >8 ≤0.5 0.5 0.5 1 (1) 1 4
879822 S. aureus 0.12 ≤0.5 0.5 1 2 (>1) 4 8
913640 S. aureus >8 >64 0.5 1 2 (>1) 2 8
934242 S. aureus 0.12 ≤0.5 0.5 0.5 2 (1) 2 8
950457 S. aureus 0.12 8 1 1 4 (2) >8 4
916083 S. aureus >8 >64 1 0.25 16 (>1) 8 8
976441 S. aureus >8 >64 4 0.5 32 (16) >8 64
972481 S. aureus 4 4 1 1 >32 (>16) >8 4
939671 S. cohnii >8 ≤0.5 1 1 0.5 (2) 1 4
939504 S. epidermidis >8 ≤0.5 ≤0.25 16 0.5 (1) 0.25 16
947675 S. epidermidis >8 16 ≤0.25 0.5 1 (0.5) >8 4
951555 S. epidermidis >8 >64 4 0.5 1 (0.5) 1 4
955639 S. epidermidis 0.12 ≤0.5 0.5 0.5 1 (1) 1 4
956923 S. epidermidis >8 16 ≤0.25 0.25 2 (0.5) >8 2
949426 S. epidermidis ≤0.06 1 ≤0.25 0.5 2 (2) >8 4
938399 S. epidermidis >8 ≤0.5 ≤0.25 0.5 8 (4) 8 2
952506 S. epidermidis >8 1 ≤0.25 0.5 8 (4) 8 4
958510 S. epidermidis ≤0.06 2 ≤0.25 1 8 (2) >8 4
934123 S. epidermidis 0.5 >64 1 128 32 (8) >8 64
939969 S. haemolyticus >8 >64 4 2 4 (4) 4 32
944662 S. sciuri >8 >64 0.5 1 16 (8) 8 32
941213 S. sciuri 0.25 ≤0.5 1 1 32 (>16) >8 4
960742 S. lutetiensis 0.03 ≤0.5 1 1 0.5 (0.5) 0.5 2
982012 S. lutetiensis ≤0.015 1 0.5 1 2 (1) 2 2
971459 S. agalactiae >32 >64 1 1 8 (8) 8 2
935557 S. agalactiae 0.03 4 0.5 1 8 (8) 4 2
935554 S. agalactiae 0.03 4 0.5 0.5 16 (16) 4 2
965031 S. gallolyticus >32 4 1 2 32 (>16) >8 4
a

Values within parentheses are the initial lefamulin MICs obtained during the surveillance studies. Q-D, quinupristin-dalfopristin.

HHS Vulnerability Disclosure